An integrated CSF-serum biomarker model for predicting clinical progression in Alzheimer's disease
{{output}}
Background: The early and accurate identification of Alzheimer's disease (AD) remains a significant clinical challenge. Integrating novel peripheral blood-based biomarkers with established cerebrospinal fluid (CSF) measures may ... ...
